ArticleClinical epigenetics2019

Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status.

Min-Wu Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.